Literature DB >> 30251164

Adult individuals with congenital, untreated, severe isolated growth hormone deficiency have satisfactory muscular function.

Alana L Andrade-Guimarães1,2, Manuel H Aguiar-Oliveira3, Roberto Salvatori4, Vitor O Carvalho2, Fabiano Alvim-Pereira1, Carlos R Araújo Daniel5, Giulliani A Moreira Brasileiro1,2, Ananda A Santana-Ribeiro1, Hugo A Santos-Carvalho1, Carla R P Oliveira3, Edgar R Vieira6, Miburge B Gois-Junior1,2,6.   

Abstract

PURPOSE: While growth hormone (GH) and the insulin-like growth factor type I (IGF-I) are known to exert synergistic actions on muscle anabolism, the consequences of prolonged GH deficiency (GHD) on muscle function have not been well defined. We have previously described a large cohort of subjects with isolated GHD (IGHD) caused by a mutation in the GH-releasing hormone receptor gene, with low serum levels of GH and IGF-I. The aim of this study was to assess muscular function in these IGHD subjects.
METHODS: A total of 31 GH-naïve IGHD (16 males) and 40 control (20 males) subjects, matched by age and degree of daily physical activity, were enrolled. Fat free mass was measured by bioelectrical impedance; muscle strength by dynamometry of handgrip, trunk extension, and knee extension; myoelectric activity and muscle fatigue by fractal dimension; conduction velocity in vastus medialis, rectus femoris, and vastus lateralis muscles by surface electromyography.
RESULTS: The IGHD group showed higher knee extension strength both when corrected for weight and fat free mass, and higher handgrip and trunk extension strength corrected by fat free mass. They also exhibit higher conduction velocity of the muscles vastus medialis, rectus femoris, and vastus lateralis, but lower free fat mass and myoelectric activity of the vastus medialis, rectus femoris and vastus lateralis. There were no differences between the two groups in fractal dimension in all studied muscles.
CONCLUSION: Individuals with untreated IGHD have better muscle strength parameters adjusted for weight and fat free mass than controls. They also exhibit greater peripheral resistance to fatigue, demonstrating satisfactory muscle function.

Entities:  

Keywords:  Dynamometry; GH; IGF-I; GHRH receptor; Muscle function

Mesh:

Substances:

Year:  2018        PMID: 30251164     DOI: 10.1007/s12020-018-1763-5

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  54 in total

Review 1.  The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults.

Authors:  Linda J Woodhouse; Annice Mukherjee; Stephen M Shalet; Shereen Ezzat
Journal:  Endocr Rev       Date:  2006-03-16       Impact factor: 19.871

2.  Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene.

Authors:  Manuel H Aguiar-Oliveira; Francielle T Oliveira; Rossana M C Pereira; Carla R P Oliveira; Amanda Blackford; Eugenia H O Valenca; Elenilde G Santos; Miburge B Gois-Junior; Rafael A Meneguz-Moreno; Vanessa P Araujo; Luis A Oliveira-Neto; Roque P Almeida; Mário A Santos; Natalia T Farias; Debora C R Silveira; Gabriel W Cabral; Flavia R Calazans; Juliane D Seabra; Tiago F Lopes; Endrigo O Rodrigues; Livia A Porto; Igor P Oliveira; Enaldo V Melo; Marco Martari; Roberto Salvatori
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

Review 3.  The effect of muscle dysfunction on bone mass and morphology.

Authors:  T S Gross; S L Poliachik; J Prasad; S D Bain
Journal:  J Musculoskelet Neuronal Interact       Date:  2010-03       Impact factor: 2.041

4.  The effect of local skin cooling before a sustained, submaximal isometric contraction on fatigue and isometric quadriceps femoris performance: A randomized controlled trial.

Authors:  Erich Hohenauer; Corrado Cescon; Tom Deliens; Peter Clarys; Ron Clijsen
Journal:  J Therm Biol       Date:  2017-02-27       Impact factor: 2.902

Review 5.  Measurement of lean body mass using bioelectrical impedance analysis: a consideration of the pros and cons.

Authors:  Giuseppe Sergi; Marina De Rui; Brendon Stubbs; Nicola Veronese; Enzo Manzato
Journal:  Aging Clin Exp Res       Date:  2016-08-27       Impact factor: 3.636

6.  Low dose of IGF-I increases cell size of skeletal muscle satellite cells via Akt/S6K signaling pathway.

Authors:  Chun-qi Gao; Rui Zhi; Zhou Yang; Hai-chang Li; Hui-chao Yan; Xiu-qi Wang
Journal:  J Cell Biochem       Date:  2015-11       Impact factor: 4.429

7.  Muscle strength in elderly adults with GH deficiency after 10 years of GH replacement.

Authors:  Galina Götherström; Mariam Elbornsson; Katharina Stibrant-Sunnerhagen; Bengt-Ake Bengtsson; Gudmundur Johannsson; Johan Svensson
Journal:  Eur J Endocrinol       Date:  2010-05-12       Impact factor: 6.664

8.  The effect of growth hormone replacement on exercise capacity in patients with GH deficiency: a metaanalysis.

Authors:  W Matthew Widdowson; James Gibney
Journal:  J Clin Endocrinol Metab       Date:  2008-08-12       Impact factor: 5.958

9.  Evaluation of central and peripheral fatigue in the quadriceps using fractal dimension and conduction velocity in young females.

Authors:  Matteo Beretta-Piccoli; Giuseppe D'Antona; Marco Barbero; Beth Fisher; Christina M Dieli-Conwright; Ron Clijsen; Corrado Cescon
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

10.  Effects of Growth Hormone Replacement on Peripheral Muscle and Exercise Capacity in Severe Growth Hormone Deficiency.

Authors:  Susana Gonzalez; Thozhukat Sathyapalan; Zeeshan Javed; Stephen L Atkin
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-23       Impact factor: 5.555

View more
  7 in total

1.  Sweat and vitamin D status in congenital, lifetime, untreated GH deficiency.

Authors:  Cynthia S Barros-Oliveira; Roberto Salvatori; Jéssica S S Dos Santos; Paula F C Santos; Alécia A Oliveira-Santos; Cindi G Marinho; Elenilde G Santos; Ângela C G B Leal; Viviane C Campos; Nayra P Damascena; Carla R P Oliveira; Manuel H Aguiar-Oliveira
Journal:  Endocrine       Date:  2019-07-10       Impact factor: 3.633

Review 2.  Growth hormone therapy in adults with growth hormone deficiency: a critical assessment of the literature.

Authors:  Xin He; Ariel L Barkan
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

3.  Vasculometabolic effects in patients with congenital growth hormone deficiency with and without GH replacement therapy during adulthood.

Authors:  Isabela Peixoto Biscotto; Valéria Aparecida Costa Hong; Rafael Loch Batista; Berenice Bilharinho Mendonca; Ivo Jorge Prado Arnhold; Luiz Aparecido Bortolotto; Luciani Renata Silveira Carvalho
Journal:  Pituitary       Date:  2020-10-24       Impact factor: 4.107

Review 4.  Growth Hormone and Aging: New Findings.

Authors:  Andrzej Bartke; Erin Hascup; Kevin Hascup; Michal M Masternak
Journal:  World J Mens Health       Date:  2021-02-03       Impact factor: 5.400

5.  Walking and postural balance in adults with severe short stature due to isolated GH deficiency.

Authors:  Ananda A Santana-Ribeiro; Giulliani A Moreira-Brasileiro; Manuel H Aguiar-Oliveira; Roberto Salvatori; Vitor O Carvalho; Claudia K Alvim-Pereira; Carlos R Araújo-Daniel; Júlia G Reis-Costa; Alana L Andrade-Guimarães; Alécia A Oliveira-Santos; Edgar R Vieira; Miburge B Gois-Junior
Journal:  Endocr Connect       Date:  2019-04       Impact factor: 3.335

6.  Insulin Sensitivity Is Not Decreased in Adult Patients With Hypopituitarism Without Growth Hormone Replacement.

Authors:  Alejandro Rosell Castillo; Aglecio Luiz de Souza; Sarah Monte Alegre; Yeelen Ballesteros Atala; Denise Engelbrecht Zantut-Wittmann; Heraldo Mendes Garmes
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-07       Impact factor: 5.555

Review 7.  GH/IGF-1 Abnormalities and Muscle Impairment: From Basic Research to Clinical Practice.

Authors:  Betina Biagetti; Rafael Simó
Journal:  Int J Mol Sci       Date:  2021-01-02       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.